Acadia Healthcare Company, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on February 6, 2015, regarding events occurring on February 5, 2015. Acadia Healthcare Company, Inc. (the "Company") entered into a definitive agreement to issue debt securities to fund a strategic acquisition.
Key Financial Metrics and Transaction Details
- Debt Issuance: The Company agreed to sell $375 million in aggregate principal amount of 5.625% Senior Notes due 2023.
- Underwriters: Merrill Lynch, Pierce, Fenner & Smith Incorporated and Jefferies LLC served as representatives of the initial purchasers.
- Use of Proceeds: Funds are designated to finance a portion of the purchase price for the planned acquisition of CRC Health Group, Inc., as well as related transaction fees and expenses.
- Offering Structure: The offering is a private placement to qualified institutional buyers under Rule 144A and to non-U.S. persons under Regulation S.
Material Changes and Conditions
The closing of the Senior Notes offering is conditioned upon and will occur concurrently with the closing of the CRC Health Group, Inc. acquisition, which was expected to take place on February 11, 2015. The filing notes an upsizing of the offering was announced in a press release issued on the same date.
Outlook, Risks, and Management Commentary
Management's primary focus in this filing is the execution of the financing required to close the CRC Health Group acquisition. The filing does not provide specific forward-looking financial guidance, revenue projections, or liquidity metrics beyond the terms of the new debt instrument. The primary contingency identified is the successful closing of the CRC acquisition, which is a condition precedent to the consummation of the notes offering.
Key Facts for Investor Verification
- Verify the final closing date of the CRC Health Group, Inc. acquisition to confirm the issuance of the Senior Notes.
- Review the full text of the Purchase Agreement (Exhibit 10) for covenants, redemption rights, and default provisions associated with the 5.625% Senior Notes.
- Confirm the total purchase price of the CRC Health Group acquisition to assess the proportion of the deal funded by this $375 million offering versus other capital sources.
- Monitor subsequent filings for the final terms of the offering, including any changes to the interest rate or maturity date.